SANUWAVE Health, Inc.
SNWV
Positions held
Your positionsSNWV isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $50.28M | Enterprise value | $61.61M | Trailing P/E | 24.35 | Forward P/E | -584.50 |
| PEG | — | Price / book | 18.04 | Beta | 1.42 | Dividend yield | 0.00% |
| Revenue growth | -3.1% | Earnings growth | — | Gross margin | 76.3% | Operating margin | -2.9% |
| Profit margin | 34.7% | ROE | — | ROA | 5.5% | Debt / equity | 7.43 |
| Current ratio | 1.28 | Free cash flow | -$2.83M | Analyst recommendation | none | Mean target | — |
| 52w high | $36.42 | 52w low | $3.92 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $9.7M | $9.6M | $13.1M | $11.5M | $10.1M | — |
| Op margin | -2.9% | -11.7% | 4.7% | 12.8% | 14.3% | — |
| Net income | -$0.7M | -$1.4M | $6.1M | $10.3M | $0.6M | — |
| Gross margin | 76.2% | 77.3% | 74.1% | 77.9% | 78.1% | — |
| Gross profit | $7.4M | $7.4M | $9.7M | $8.9M | $7.8M | — |
| Operating income | -$0.3M | -$1.1M | $0.6M | $1.5M | $1.4M | — |
- Revenue +1% vs prior quarter ($9.7M vs $9.6M).
- Gross margin 76.2% (was 77.3% prior quarter).
- Operating margin expanded to -2.9%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $44.1M | $32.6M | $20.4M | $16.7M | — |
| Op margin | 11.2% | 11.8% | -2.6% | -53.5% | — |
| Net income | $11.8M | -$33.1M | -$25.8M | -$10.3M | — |
| Gross margin | 77.1% | 75.2% | 70.4% | 74.1% | — |
| Gross profit | $34.0M | $24.6M | $14.4M | $12.4M | — |
| Operating income | $4.9M | $3.8M | -$0.5M | -$9.0M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-08-07 · SANUWAVE Health Inc (SNWV) (Q2 2026) Earnings Call Highlights: Record Applicator Sales Offset ...
2026-08-07 · Sanuwave Health Q2 Earnings Call Highlights
2026-08-07 · SANUWAVE Health, Inc. Q2 2026 Earnings Call Summary
2026-08-06 · Sanuwave Announces Q2 FY2026 Financial Results
2026-08-06 · Sanuwave Announces Q2 FY2026 Financial Results
2026-08-06 · Earnings To Watch: SANUWAVE Health Inc (SNWV) Q2 2026 -- GF Value Sees 166% Upside
2026-07-30 · Sanuwave Will Host a Conference Call on August 7, 2026 at 8:30 AM (ET) to Present Q2 2026 Financial Results
2026-07-13 · Sanuwave Health's Preliminary Q2 Revenue Tops Revised Guidance
2026-07-13 · Sanuwave Health Reports Preliminary Q2 2026 Revenue of $9.6–$9.8 Million, Above High End of Revised Guidance
Price (daily)
Full chart · RSI · MACD · patterns